An open-label phase 1/2 study of DCC-3009 monotherapy in patients with advanced gastrointestinal stromal tumor. PYNNACLE Phase 1/2 basket study (NCT04585750). · Prior standard therapy or ineligible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback